Asciminib continued to improve outcomes when compared to investigator-selected TKIs in patients with newly diagnosed, Ph+ CML-CP in the ASC4FIRST trial.

Billing for patient portal messages is associated with a modest decrease in patient-initiated message volume, data suggest.

The FDA has approved subcutaneous nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) to treat a range of solid tumor malignancies.

(HealthDay News) — Cannabidiol (CBD) appears safe and may reduce anxiety in patients with advanced breast cancer, according to a study published in JAMA Network Open.

Norovirus cases are on the rise in the United States this winter, according to data from the US Centers for Disease Control and Prevention.

This page includes links to articles highlighting the top breast cancer research published on Cancer Therapy Advisor in 2024.

Many patients with multiple myeloma experience persistent pain and use opioids to manage that pain even after they achieve remission, a survey suggests.

(HealthDay News) — Health care spending in the United States reached $4.9 trillion ($14,570 per person) in 2023, according to data published in Health Affairs. Researchers found that US health care ...

Bicistronic CAR T-cell therapy can produce durable complete responses in pediatric patients with relapsed or refractory B-ALL, data suggest.